Stent maker paying $22M to end probe

Bloomberg News/Boston Globe, December 24, 2009

Boston Scientific Corp., the world's biggest maker of heart stents, has agreed to pay $22 million to settle allegations the company's Guidant unit reportedly used clinical studies to pay kickbacks to doctors for using its products. Guidant paid physicians $1,000 to $1,500 each to participate in one of four studies it said were designed to assess the performance of pacemakers and defibrillators, the US Department of Justice said in a prepared statement. In reality, the company was paying doctors to select Guidant devices over competing products, the government said. Boston Scientific will enter into a corporate integrity agreement, which requires its cardiac rhythm management unit to disclose payments to doctors on its Web site.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2014 a division of BLR All rights reserved.